Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.500
-0.040 (-2.60%)
At close: May 13, 2025, 4:00 PM
1.500
0.00 (0.00%)
Pre-market: May 14, 2025, 9:03 AM EDT

Editas Medicine Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1261058275971,7964,335
Upgrade
Market Cap Growth
-84.14%-87.33%38.68%-66.78%-58.56%188.64%
Upgrade
Enterprise Value
-64-1224161391,1683,820
Upgrade
Last Close Price
1.501.2710.138.8726.5570.11
Upgrade
PS Ratio
3.463.2410.5930.2770.3147.77
Upgrade
PB Ratio
2.010.782.371.653.2411.01
Upgrade
P/TBV Ratio
2.010.782.371.653.2411.01
Upgrade
EV/Sales Ratio
--5.327.0745.7142.10
Upgrade
Debt / Equity Ratio
0.500.260.110.120.050.07
Upgrade
Asset Turnover
0.100.080.150.030.040.17
Upgrade
Quick Ratio
3.033.715.275.8110.677.01
Upgrade
Current Ratio
3.083.755.395.9410.827.20
Upgrade
Return on Equity (ROE)
-140.82%-98.10%-43.17%-48.22%-40.64%-35.36%
Upgrade
Return on Assets (ROA)
-36.80%-35.52%-20.87%-23.70%-19.31%-15.58%
Upgrade
Return on Capital (ROIC)
-61.37%-53.82%-26.76%-28.68%-24.15%-23.70%
Upgrade
Earnings Yield
-200.07%-226.16%-18.52%-36.95%-10.72%-2.68%
Upgrade
FCF Yield
-171.44%-209.00%-16.55%-30.42%-9.56%-4.31%
Upgrade
Buyback Yield / Dilution
-4.29%-8.39%-10.63%-1.55%-15.37%-17.26%
Upgrade
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q